<--- Back to Details
First PageDocument Content
Universal identifiers / Pharmaceutical industry / Drug safety / Pharmaceutical sciences / Object identifier / Medicine / International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use / Electronic Common Technical Document / IFPMA / Identifiers / Clinical research / Research
Universal identifiers
Pharmaceutical industry
Drug safety
Pharmaceutical sciences
Object identifier
Medicine
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use
Electronic Common Technical Document
IFPMA
Identifiers
Clinical research
Research

E2B(R3) OID Information Paper

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 209,38 KB

Share Document on Facebook

Similar Documents

The EVMS Autism Spectrum Disorder Program was started by Maria Urbano, M.D., and Kathrin Hartmann, Ph.D., in 2010 to provide clinical services, research, and community outreach to individuals and their families for Autis

The EVMS Autism Spectrum Disorder Program was started by Maria Urbano, M.D., and Kathrin Hartmann, Ph.D., in 2010 to provide clinical services, research, and community outreach to individuals and their families for Autis

DocID: 1vrwY - View Document

Towards a Composite Clinical Endpoint: Identifying a Core Set of Patient and Caregiver Relevant Outcome Measures Through Qualitative Research on the Global Impact of Dravet Syndrome Rima Nabbout1, Stephane Auvin2, Cather

Towards a Composite Clinical Endpoint: Identifying a Core Set of Patient and Caregiver Relevant Outcome Measures Through Qualitative Research on the Global Impact of Dravet Syndrome Rima Nabbout1, Stephane Auvin2, Cather

DocID: 1vpIt - View Document

Clinical Research Registration at Public Registry

Clinical Research Registration at Public Registry

DocID: 1vnxr - View Document

Grattoni Alessandro, Ph.D. Chairman, The Department of Nanomedicine, The Houston Methodist Research Institute, Houston, Texas (USA) Dr. Grattoni’s research is dedicated to the development and clinical translation of im

Grattoni Alessandro, Ph.D. Chairman, The Department of Nanomedicine, The Houston Methodist Research Institute, Houston, Texas (USA) Dr. Grattoni’s research is dedicated to the development and clinical translation of im

DocID: 1vi9N - View Document

Clinical & Translational Research 101 Thursday, August 10, 2017 Time Location

Clinical & Translational Research 101 Thursday, August 10, 2017 Time Location

DocID: 1vglz - View Document